Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016-2018.

Wesley MG, Soto G, Arriola CS, Gonzales M, Newes-Adeyi G, Romero C, Veguilla V, Levine MZ, Silva M, Ferdinands JM, Dawood FS, Reynolds SB, Hirsch A, Katz M, Matos E, Ticona E, Castro J, Castillo M, Bravo E, Cheung A, Phadnis R, Martin ET, Tinoco Y, Neyra Quijandria JM, Azziz-Baumgartner E, Thompson MG; VIP Cohort Study Working Group.

Influenza Other Respir Viruses. 2020 Apr 5. doi: 10.1111/irv.12737. [Epub ahead of print]

2.

Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan.

Monto AS, DeJonge P, Callear AP, Bazzi LA, Capriola S, Malosh RE, Martin ET, Petrie JG.

J Infect Dis. 2020 Apr 4. pii: jiaa161. doi: 10.1093/infdis/jiaa161. [Epub ahead of print]

PMID:
32246136
3.

Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.

Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, DaSilva J, Le S, Stark T, Kondor RJ, Barnes JR, Wentworth DE, Brammer L, Fry AM, Patel MM, Flannery B.

MMWR Morb Mortal Wkly Rep. 2020 Feb 21;69(7):177-182. doi: 10.15585/mmwr.mm6907a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):358.

4.

Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017.

Doyle JD, Beacham L, Martin ET, Talbot HK, Monto A, Gaglani M, Middleton DB, Silveira FP, Zimmerman RK, Alyanak E, Smith ER, Flannery BL, Rolfes M, Ferdinands JM.

Clin Infect Dis. 2020 Feb 18. pii: ciaa160. doi: 10.1093/cid/ciaa160. [Epub ahead of print]

PMID:
32067049
5.

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017.

Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, Spencer S, Fry AM, Flannery B.

Clin Infect Dis. 2020 Feb 1. pii: ciaa102. doi: 10.1093/cid/ciaa102. [Epub ahead of print]

PMID:
32006430
6.

Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia.

Albin OR, Henig O, Patel TS, Valley TS, Pogue JM, Petty LA, Mills JP, Brancaccio A, Martin ET, Kaye KS.

Clin Infect Dis. 2019 Dec 13. pii: ciz1187. doi: 10.1093/cid/ciz1187. [Epub ahead of print]

PMID:
31832641
7.

Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts.

Valesano AL, Fitzsimmons WJ, McCrone JT, Petrie JG, Monto AS, Martin ET, Lauring AS.

J Virol. 2020 Feb 14;94(5). pii: e01710-19. doi: 10.1128/JVI.01710-19. Print 2020 Feb 14.

PMID:
31801858
8.

Influenza Vaccine Effectiveness in the Inpatient Setting; Evaluation of Potential Bias in the Test Negative Design by use of Alternate Control Groups.

Segaloff HE, Cheng B, Miller AV, Petrie JG, Malosh RE, Cheng C, Lauring AS, Lamerato L, Ferdinands JM, Monto AS, Martin ET.

Am J Epidemiol. 2019 Nov 1. pii: kwz248. doi: 10.1093/aje/kwz248. [Epub ahead of print]

PMID:
31673696
9.

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, Kniss K, Budd AP, Brammer L, Stark TJ, Barnes JR, Wentworth DE, Fry AM, Patel M.

J Infect Dis. 2020 Jan 1;221(1):8-15. doi: 10.1093/infdis/jiz543.

PMID:
31665373
10.

Communicable Disease Outbreaks in Michigan Child Care Centers Compared With State and Regional Epidemics, 2014-2017.

DeJonge P, Martin ET, Hayashi M, Johnson S, Hashikawa AN.

Am J Public Health. 2019 Dec;109(12):1707-1710. doi: 10.2105/AJPH.2019.305355. Epub 2019 Oct 17.

PMID:
31622146
11.

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.

Gilbert PB, Fong Y, Juraska M, Carpp LN, Monto AS, Martin ET, Petrie JG.

BMC Infect Dis. 2019 May 22;19(1):453. doi: 10.1186/s12879-019-4049-5.

12.

Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness.

Petrie JG, Martin ET, Zhu Y, Wyatt DG, Kaniclides A, Ferdinands JM, Monto AS, Trabue C, Talbot HK.

Vaccine. 2019 Jun 27;37(29):3849-3855. doi: 10.1016/j.vaccine.2019.05.051. Epub 2019 May 18.

PMID:
31113675
13.

Social patterning of acute respiratory illnesses in the Household Influenza Vaccine Evaluation (HIVE) Study 2014-2015.

Malosh RE, Noppert GA, Zelner J, Martin ET, Monto AS.

Epidemiol Infect. 2019 Jan;147:e185. doi: 10.1017/S0950268819000748.

14.

Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study.

Monto AS, Malosh RE, Evans R, Lauring AS, Gordon A, Thompson MG, Fry AM, Flannery B, Ohmit SE, Petrie JG, Martin ET; HIVE Study Research Staff.

Int J Epidemiol. 2019 Aug 1;48(4):1040-1040g. doi: 10.1093/ije/dyz086. No abstract available.

15.

Variation in surface decontamination practices among Michigan child care centers compared to state and national guidelines.

DeJonge P, Martin ET, Hayashi M, Hashikawa AN.

Am J Infect Control. 2019 Oct;47(10):1176-1180. doi: 10.1016/j.ajic.2019.03.019. Epub 2019 Apr 27.

PMID:
31036400
16.

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.

Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Foust A, Sessions W, Berman L, Garten RJ, Barnes JR, Wentworth DE, Fry AM, Patel MM, Flannery B.

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):135-139. doi: 10.15585/mmwr.mm6806a2.

17.

Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015-2016, 2016-2017, and 2017-2018.

Segaloff HE, Leventer-Roberts M, Riesel D, Malosh RE, Feldman BS, Shemer-Avni Y, Key C, Monto AS, Martin ET, Katz MA.

Clin Infect Dis. 2019 Nov 27;69(12):2153-2161. doi: 10.1093/cid/ciz125.

PMID:
30753347
18.

Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.

Petrie JG, Martin ET, Truscon R, Johnson E, Cheng CK, McSpadden EJ, Malosh RE, Lauring AS, Lamerato LE, Eichelberger MC, Ferdinands JM, Monto AS.

Vaccine. 2019 Feb 28;37(10):1284-1292. doi: 10.1016/j.vaccine.2019.01.055. Epub 2019 Feb 7.

19.

Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.

Zelner J, Petrie JG, Trangucci R, Martin ET, Monto AS.

J Infect Dis. 2019 Jun 5;220(1):12-19. doi: 10.1093/infdis/jiz055.

PMID:
30722022
20.

Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.

Levine MZ, Martin ET, Petrie JG, Lauring AS, Holiday C, Jefferson S, Fitzsimmons WJ, Johnson E, Ferdinands JM, Monto AS.

J Infect Dis. 2019 May 24;219(12):1904-1912. doi: 10.1093/infdis/jiz049.

PMID:
30721982
21.

Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans.

Christensen SR, Toulmin SA, Griesman T, Lamerato LE, Petrie JG, Martin ET, Monto AS, Hensley SE.

J Virol. 2019 Apr 3;93(8). pii: e02134-18. doi: 10.1128/JVI.02134-18. Print 2019 Apr 15.

22.

Sequential Regulation of Maternal mRNAs through a Conserved cis-Acting Element in Their 3' UTRs.

Flora P, Wong-Deyrup SW, Martin ET, Palumbo RJ, Nasrallah M, Oligney A, Blatt P, Patel D, Fuchs G, Rangan P.

Cell Rep. 2018 Dec 26;25(13):3828-3843.e9. doi: 10.1016/j.celrep.2018.12.007.

23.

Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, Silveira FP, Talbot HK, Zimmerman R, Alyanak E, Strickland C, Spencer S, Fry AM; HAIVEN Study Investigators .

J Infect Dis. 2019 Sep 13;220(8):1265-1275. doi: 10.1093/infdis/jiy723.

PMID:
30561689
24.

Predictors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization among nursing facility patients.

Heinze K, Kabeto M, Martin ET, Cassone M, Hicks L, Mody L.

Am J Infect Control. 2019 Apr;47(4):415-420. doi: 10.1016/j.ajic.2018.09.026. Epub 2018 Nov 28.

25.

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.

Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B.

Vaccine. 2018 Dec 18;36(52):8047-8053. doi: 10.1016/j.vaccine.2018.10.093. Epub 2018 Nov 9.

26.

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011-12-2015-16.

Appiah GD, Chung JR, Flannery B, Havers FP, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM.

Influenza Other Respir Viruses. 2019 Mar;13(2):133-137. doi: 10.1111/irv.12616. Epub 2018 Dec 19.

27.

Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.

Hirsch A, Katz MA, Laufer Peretz A, Greenberg D, Wendlandt R, Shemer Avni Y, Newes-Adeyi G, Gofer I, Leventer-Roberts M, Davidovitch N, Rosenthal A, Gur-Arie R, Hertz T, Glatman-Freedman A, Monto AS, Azziz-Baumgartner E, Ferdinands JM, Martin ET, Malosh RE, Neyra Quijandría JM, Levine M, Campbell W, Balicer R, Thompson MG; SHIRI workgroup.

BMC Infect Dis. 2018 Nov 6;18(1):550. doi: 10.1186/s12879-018-3444-7.

28.

Tip60 complex promotes expression of a differentiation factor to regulate germline differentiation in female Drosophila.

McCarthy A, Deiulio A, Martin ET, Upadhyay M, Rangan P.

Mol Biol Cell. 2018 Nov 26;29(24):2933-2945. doi: 10.1091/mbc.E18-06-0385. Epub 2018 Sep 19.

29.

Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season.

Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM; US Flu VE Investigators.

Clin Infect Dis. 2019 May 17;68(11):1798-1806. doi: 10.1093/cid/ciy775.

30.

Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness.

Rajput C, Han M, Bentley JK, Lei J, Ishikawa T, Wu Q, Hinde JL, Callear AP, Stillwell TL, Jackson WT, Martin ET, Hershenson MB.

JCI Insight. 2018 Aug 23;3(16). pii: 121882. doi: 10.1172/jci.insight.121882. eCollection 2018 Aug 23.

31.

Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo.

Davis AKF, McCormick K, Gumina ME, Petrie JG, Martin ET, Xue KS, Bloom JD, Monto AS, Bushman FD, Hensley SE.

J Virol. 2018 Sep 12;92(19). pii: e00859-18. doi: 10.1128/JVI.00859-18. Print 2018 Oct 1.

32.

Usefulness of Serum Procalcitonin as a Markerfor Coexisting Infection in Patients With Acute Myocardial Infarction.

Vitkon-Barkay I, Lazarovitch T, Marchaim D, Zaidenstein R, Temkin E, Martin ET, Segaloff HE, Litovchik I, Rum V, Richter C, Tzuman O, Vered Z, Minha S.

Am J Cardiol. 2018 Sep 1;122(5):729-734. doi: 10.1016/j.amjcard.2018.05.004. Epub 2018 Jun 2.

PMID:
30037423
33.

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014-2015 and 2015-2016.

Segaloff HE, Petrie JG, Malosh RE, Cheng CK, McSpadden EJ, Ferdinands JM, Lamerato L, Lauring AS, Monto AS, Martin ET.

Epidemiol Infect. 2018 Aug;146(11):1350-1358. doi: 10.1017/S0950268818001486. Epub 2018 Jun 8.

34.

Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.

Garretson TA, Petrie JG, Martin ET, Monto AS, Hensley SE.

Vaccine. 2018 Jun 27;36(28):4095-4101. doi: 10.1016/j.vaccine.2018.05.086. Epub 2018 May 31.

35.

Heterotypic Infection and Spread of Rhinovirus A, B, and C among Childcare Attendees.

Martin ET, Kuypers J, Chu HY, Foote S, Hashikawa A, Fairchok MP, Englund JA.

J Infect Dis. 2018 Aug 14;218(6):848-855. doi: 10.1093/infdis/jiy232.

36.

Stochastic processes constrain the within and between host evolution of influenza virus.

McCrone JT, Woods RJ, Martin ET, Malosh RE, Monto AS, Lauring AS.

Elife. 2018 May 3;7. pii: e35962. doi: 10.7554/eLife.35962.

37.

Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding.

Davis BM, Foxman B, Monto AS, Baric RS, Martin ET, Uzicanin A, Rainey JJ, Aiello AE.

Influenza Other Respir Viruses. 2018 Sep;12(5):582-590. doi: 10.1111/irv.12563. Epub 2018 Jul 24.

38.

Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus.

Luther MK, Parente DM, Caffrey AR, Daffinee KE, Lopes VV, Martin ET, LaPlante KL.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02252-17. doi: 10.1128/AAC.02252-17. Print 2018 May.

39.

Outcomes and Resource Use Among Overweight and Obese Children With Sepsis in the Pediatric Intensive Care Unit.

Peterson LS, Gállego Suárez C, Segaloff HE, Griffin C, Martin ET, Odetola FO, Singer K.

J Intensive Care Med. 2020 May;35(5):472-477. doi: 10.1177/0885066618760541. Epub 2018 Feb 22.

PMID:
29471722
40.

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, Barnes JR, Spencer S, Fry AM.

MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185. doi: 10.15585/mmwr.mm6706a2.

41.

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B.

Vaccine. 2018 Feb 28;36(10):1272-1278. doi: 10.1016/j.vaccine.2018.01.045.

42.

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Griffin MR, Keipp Talbot H, Treanor JJ, Wentworth DE, Fry AM.

J Infect Dis. 2018 Jun 20;218(2):189-196. doi: 10.1093/infdis/jix634.

43.

Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials.

Malosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS.

Clin Infect Dis. 2018 May 2;66(10):1492-1500. doi: 10.1093/cid/cix1040.

PMID:
29186364
44.

The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.

Malosh RE, Martin ET, Ortiz JR, Monto AS.

Vaccine. 2018 Jan 2;36(1):141-147. doi: 10.1016/j.vaccine.2017.11.018. Epub 2017 Nov 20. Review.

45.

Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016.

Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson ML, Monto AS, Martin ET, Belongia EA, McLean HQ, Fry AM, Havers FP.

Clin Infect Dis. 2018 Mar 19;66(7):1035-1041. doi: 10.1093/cid/cix922.

46.

The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.

Petrie JG, Malosh RE, Cheng CK, Ohmit SE, Martin ET, Johnson E, Truscon R, Eichelberger MC, Gubareva LV, Fry AM, Monto AS.

Clin Infect Dis. 2017 Oct 30;65(10):1644-1651. doi: 10.1093/cid/cix608.

47.

Respiratory syncytial virus hospitalization in middle-aged and older adults.

Malosh RE, Martin ET, Callear AP, Petrie JG, Lauring AS, Lamerato L, Fry AM, Ferdinands J, Flannery B, Monto AS.

J Clin Virol. 2017 Nov;96:37-43. doi: 10.1016/j.jcv.2017.09.001. Epub 2017 Sep 7.

48.

Web-Based Surveillance of Illness in Childcare Centers.

Schellpfeffer N, Collins A, Brousseau DC, Martin ET, Hashikawa A.

Health Secur. 2017 Sep/Oct;15(5):463-472. doi: 10.1089/hs.2016.0124. Epub 2017 Sep 22.

49.

The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults.

Segaloff HE, Evans R, Arshad S, Zervos MJ, Archer C, Kaye KS, Martin ET.

J Med Virol. 2018 Feb;90(2):212-218. doi: 10.1002/jmv.24946. Epub 2017 Sep 25.

50.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.

Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B.

N Engl J Med. 2017 Aug 10;377(6):534-543. doi: 10.1056/NEJMoa1700153.

Supplemental Content

Loading ...
Support Center